This post provides followup to a previous post: Dreaded Nausea.
A recent study (AC Russell, AL Stone, LS Walker, Clin Gastroenterol Hepatol 2017; 15: 706-11) provides even more reasons to dread nausea.
This prospective study of 871 children with functional abdominal pain examined the comorbidity of nausea. Followup data were collected from 392 patients at median of 8.7 years later.
- At baseline, 44.8% of patients reported nausea. This group reported worse abdominal pain, somatic symptoms and depression than those without nausea.
- At followup, “those with nausea in childhood continue to have more severe GI (P<.001) and somatic symptoms (P=.003)…as well as higher levels of anxiety (P=.02) and depression (P=.02).” Anxiety and depression remained significant after controlling for baseline abdominal pain severity.
- At the followup evaluation, the prevalence of any functional GI disorder (FGID) was 85 (48%) of those who had nausea at baseline compared with 77 (36%) for those without nausea at baseline.
In their discussion, the authors reiterate findings from previous work on this patient sample: “current and lifetime diagnoses of anxiety disorders are substantially higher in adolescents with a history of FAP [functional abdominal pain] compared with healthy controls (lifetime, 51% vs. 20%; current 30% vs 12%). The lifetime risk of depressive disorder is also significantly higher in those with FAP (40% vs. 16%).” They also note some limitations in their work, including the absence of formal screening for postural orthostatic tachycardia syndrome (POTS).
My take (borrowed from authors): This study “suggests that nausea is more than just a comorbid symptom of FAP and may have a different underlying etiology” and increases likelihood of persistent symptoms as well as anxiety and depression.
Briefly noted: RJ Shulman et al. Clin Gastroenterol Hepatol 2017; 15: 712-9. This randomized, double-blind study showed that added psyllium reduced frequency (but not severity) of abdominal pain in children (n=103) with irritable bowel syndrome. Psyllium was dosed at 6 g/day for 7-11 year olds, and 12 g for 12-18 year olds. Interestingly, this study did not show that psyllium caused a difference in normal stools or other mechanistic reasons for improvement, like breath hydrogen, breath methane, intestinal permeability or microbiome composition.
- Brave New World: Psychotropic Manipulation & Pediatric …
- Understanding Idiopathic Nausea | gutsandgrowth
- NEJM: Functional Dyspepsia | gutsandgrowth
- Does buspirone help functional dyspepsia? | gutsandgrowth
- A 6-Year Study of Amitriptyline, Escitalopram, and Functional
- Anxiety and Functional Abdominal Pain | gutsandgrowth
- Cognitive Behavioral Therapy for Childhood Abdominal Pain